Skip to main content
Login
Contact
Subscribe
Search form
Search
The Antlers American
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
Pushmataha County Chamber
Antlers Public Schools
Clayton Public School
Deer Capitol Tourism Association
Little Dixie Community Action Agency
Moyers Public School
Rattan Public Schools
Wildlife Heritage Center
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Aldeyra Therapeu
(NQ:
ALDX
)
5.660
USD
-0.280 (-4.71%)
Official Closing Price
/ Updated:
4:00 PM EDT, Oct 18, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
127,300
Open
5.920
Bid (Size)
5.150 (5)
Ask (Size)
6.190 (5)
Prev. Close
5.940
Today's Range
5.560 - 5.920
52wk Range
4.310 - 13.15
Shares Outstanding
20,109,394
Dividend Yield
N/A
Performance
YTD
-33.49%
-33.49%
1 Month
-1.57%
-1.57%
3 Month
+7.40%
+7.40%
6 Month
-26.59%
-26.59%
1 Year
-54.43%
-54.43%
Top News
More News
ZAGENO Appoints Josef H. von Rickenbach as Chairman of its Board of Directors
October 16, 2019
from
GlobeNewswire News Releases
Aldeyra Therapeutics to Present at Ophthalmology Innovation Summit at American Academy of Ophthalmology 2019 Annual Meeting
October 07, 2019
Aldeyra Therapeutics will discuss its Phase 3 ocular programs on Thursday, October 10 at the Ophthalmology Innovation Summit in San Francisco.
Read More
from
Business Wire News Releases
More News
Read More
Aldeyra Therapeutics to Present Phase 3 ALLEVIATE Trial Results in Allergic Conjunctivitis at American Academy of Ophthalmology 2019 Annual Meeting
September 26, 2019
from
Business Wire News Releases
Aldeyra Therapeutics to Present at 2019 Cantor Global Healthcare Conference
September 25, 2019
from
Business Wire News Releases
Aldeyra Therapeutics Receives Fast Track Designation for ADX-2191 for the Prevention of Proliferative Vitreoretinopathy
September 24, 2019
from
Business Wire News Releases
4 Stocks To Watch For October 14, 2019
October 14, 2019
category
Trading Ideas
,
Markets
,
Market News
, and 9 more.
from
Benzinga
IWO's Holdings Imply 29% Gain Potential
October 10, 2019
category
ETFs
from
ETF Channel
Aldeyra Therapeutics to Participate in Upcoming Investor Conferences
August 28, 2019
from
Business Wire News Releases
Commit To Buy Aldeyra Therapeutics At $5, Earn 42% Annualized Using Options
October 07, 2019
category
Stocks
from
Market News Video
Top Buys by Top Brass: CEO Brady's $263.3K Bet on ALDX
September 20, 2019
category
Stocks
from
Market News Video
Bargain Hunters Take Note: Insider Cluster-Buying At ALDX
September 11, 2019
category
Stocks
from
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
